Clinical Trial

Electrical Stimulation stimulation restores movement and sensory feedback after severe spinal injury

by

Spinal Cord Stimulation: A New Era of Movement and Sensation Researchers at Brown University, Rhode Island Hospital, and VA Providence Healthcare have achieved a significant breakthrough in restoring communication across damaged spinal cords. A recent clinical trial, published in Nature Biomedical Engineering, demonstrates the potential of electrical stimulation to re-establish both motor control and sensory … Read more

DNA origami vaccine platform shows promise against multiple infectious viruses

by

Beyond COVID-19: The Next Generation of mRNA and DNA Vaccine Technology The rapid development and deployment of mRNA vaccines during the COVID-19 pandemic marked a turning point in global healthcare. These vaccines, initially administered in December 2020, are estimated to have prevented at least 14.4 million deaths in the first year alone. This success has … Read more

Reduce clinical trial size through pre-stratification

by

Precision Medicine’s New Frontier: Smaller Trials, Bigger Insights The future of clinical trials is shifting. A growing emphasis on precision medicine – tailoring treatments to individual patient characteristics – is driving a demand for more efficient and targeted research. A key strategy gaining traction is pre-stratification, a process of identifying patients most likely to respond … Read more

Mushroom-derived supplement may be the key to longer vaccine protection and fewer side effects, UCSD study finds | News

by

Mushroom Power: Could Fungi Be the Future of Vaccine Effectiveness? Researchers at the University of California San Diego School of Medicine have uncovered a potentially groundbreaking link between medicinal mushrooms and improved vaccine response. A recent study, published in BMC Immunology on March 3, 2026, suggests a natural fungal supplement could be a game-changer in … Read more

Pharmacokinetics and Safety of VV116 in Subjects With Mild or Moderate Hepatic Impairment Compared With Healthy Controls: A Phase I, Open-Label Study

by

The Future of Oral Antivirals: VV116 and the Promise of Targeted COVID-19 Treatment The quest for effective and convenient oral treatments for COVID-19 continues, with VV116 (too known as Mindvy or JT001) emerging as a promising candidate. This novel drug, a deuterated form of remdesivir hydrobromide, is undergoing rigorous testing to determine its efficacy and … Read more

Mount Gambier man given three months to live documents battle with rare lymphoma

by

Mount Gambier Man’s Rare Cancer Battle Highlights Advances and Challenges in Lymphoma Treatment In early October 2025, 49-year-old Ben Whitehead of Mount Gambier, South Australia, experienced a dramatic shift in his health. What began as a loss of physical stamina – going from running 130 kilometers a week to struggling with basic tasks – quickly … Read more

Short-duration psychedelic therapy shows promise for major depression treatment

by

The Future of Depression Treatment: Could Short-Acting Psychedelics Be a Game Changer? A recent phase IIa clinical trial published in Nature Medicine is generating excitement in the field of mental health. The study explored the potential of dimethyltryptamine (DMT), a short-acting psychedelic, as a rapid treatment for major depressive disorder (MDD). While still early days, … Read more

Telehealth boosts uptake of genetic testing among adult survivors of childhood cancers

by

Telehealth: Expanding Genetic Testing for Childhood Cancer Survivors Adults who survived childhood cancer face a heightened risk of developing secondary cancers, like breast, colorectal, sarcomas, and thyroid cancer. While previous cancer treatments contribute to this risk, a significant portion – up to 13 percent – is linked to hereditary predispositions. Fortunately, a recent clinical trial … Read more

High adherence and safety found in short TB treatments

by

Shorter TB Treatment Regimens: A Turning Point in Global Health A recent clinical trial, led by researchers at the Johns Hopkins School of Medicine, has revealed promising results in the fight against tuberculosis (TB). The study, published in PLOS Medicine on February 10th, demonstrates that one- and three-month antibiotic treatments are equally effective and well-tolerated … Read more

Tirzepatide shows dual benefits in sleep apnea trial improving metabolism and reducing inflammation

by

Tirzepatide: A New Approach to Tackling Sleep Apnea and Cardiometabolic Risk? Recent findings from the SURMOUNT-OSA trial, published in Nature Medicine, suggest a potentially groundbreaking shift in how we manage the complex interplay between obstructive sleep apnea (OSA), obesity, and cardiometabolic health. The study highlights the significant benefits of tirzepatide, a dual GIP and GLP-1 … Read more

© 2026 Newsy Today. All rights reserved.


For contact, advertising, copyright, issues email: [email protected]

For contact, advertising, copyright, issues email: [email protected]